-
Dr. Ryan Woods to offer regenerative medicine at Wisconsin orthopedic center
In February, Ryan Woods, MD, will provide regenerative medicine services to patients at Orthopedics & Sports Medicine BayCare Clinic in Manitowoc, Wis., according to the Herald Times Reporter. -
HSS orthopedic surgeon joins NanoFUSE Biologics' growing scientific advisory board
NanoFUSE Biologics appointed Answorth Allen, MD, Jan. 16 to its scientific advisory board, reports Benzinga. -
4 developments in spine and orthopedics biologics
The potential of spine-targeted biologics is immense and quickly developing. Here are four recent stories on notable developments or recognitions: -
Dr. Mohamad Khazaei recognized for stem cell research on spinal cord injuries
Stem Cells Translational Medicine recently awarded Mohamad Khazaei, PhD, its Young Investigator Award for his research on cell-based treatments for spinal cord injuries, reports News Medical Life Sciences. -
Bone Biologics product promotes bone growth — 4 insights
Orthobiologic developer Bone Biologics said its rhNELL-1 product promoted bone formation in advanced spine models. -
Humans have a 'cellular clock' that controls spine growth, researchers confirm
Developmental biologist Olivier Pourquié, PhD, identified a cellular segmentation clock-like mechanism in humans that controls spine development, The Harvard Gazette reports. -
Ortho-biologics company launches cellular bone allograft
Ortho-biologics company Royal Biologics launched Magnus, a DMSO-free viable cellular bone allograft, the first of its kind to be DMSO-free. -
Dr. Darren Lebl joins NanoFUSE Biologics scientific advisory board: 4 things to know
NanoFUSE Biologics named Darren Lebl, MD, to its scientific advisory board. -
Bioventus, BCBS of Michigan partner in knee OA initiative — 3 things to know
Bioventus is partnering with Blue Cross Blue Shield of Michigan to provide its knee osteoarthritis treatments to Medicare Advantage and Commercial patients, beginning Jan. 1, 2020. -
9 big developments in stem cell research for spine in 2019
Here are nine key developments in stem cell research for spine this year: -
$2.1M spinal muscular atrophy drug administered to 1-year-old girl at Michigan hospital
Grand Rapids, Mich.-based Helen DeVos Children's Hospital provided a $2.1 million gene therapy drug for spinal muscular atrophy to a one-year-old girl in November, reports Fox 47 News. -
Irish researcher awarded $2.2M grant for project to study spinal regeneration
Dr. Conor Buckley, director of biomedical engineering at Trinity College Dublin in Ireland, received a European Research Grant to study spinal regeneration on Dec. 10, reports The Irish Times. -
Anika launches new regenerative therapy for bone repair procedures
Anika launched Tactoset, its new surgical therapy for bone repair procedures at the Orthopaedic Summit 2019: Evolving Techniques, which is taking place in Las Vegas, Dec. 11-14. -
Drs. Bert Mandelbaum, Jason Dragoo on the future of The Biologics Alliance
While biologic-based treatments have loads of promise when it comes to orthopedics, illegal actors are tarnishing the space and promoting false narratives that hurt scientific advances. -
Dr. Melissa Carpenter becomes ElevateBio's chief scientific officer of regenerative medicine
ElevateBio appointed Melissa Carpenter, PhD, as chief scientific officer of regenerative medicine Dec. 9. -
EmCyte adipose lipoplasty harvesting system gains FDA clearance for neurosurgery, orthopedics
The FDA cleared EmCyte's Progenikine Concentrating System for adipose lipoplasty for procedures in several specialties including neurosurgery and orthopedics. -
Mayo Clinic exploring spine-facing stem cell therapy — 5 insights
Rochester, Minn.-based Mayo Clinic is in the midst of analyzing a stem cell therapy for spine injuries, the Minneapolis StarTribune reports. -
4 professional societies partner to form The Biologics Alliance
The Arthroscopy Association of North America, American Orthopaedic Society for Sports Medicine, International Cartilage Repair Society and ON Foundation have partnered to form The Biologics Alliance. -
UA Little Rock receives $750K to support scaffold for bone regeneration
The U.S. Department of Defense's Peer Reviewed Orthopaedic Research Program recently provided the University of Arkansas at Little Rock with a $750,000 grant to study the NuCress scaffold's ability to combat infection while regenerating bone, reports Newswise. -
SpineOvations begins clinical study of DiscSeal for lumbar pain in Australia
SpineOvations initiated a pilot clinical study of DiscSeal in patients suffering from lumbar spine pain after recently receiving Australian regulatory approval.
Page 14 of 34